Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous-Cell Lung Cancer × Platinum Compounds × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 6 Ovarian Neoplasms 5 Esophageal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Neoplasm Metastasis 2 Urinary Bladder Neoplasms 1 Squamous-Cell Lung Cancer 1 Retinoblastoma 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Resectable Non-small Cell Lung Cancer 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Nonsquamous Non-small Cell Lung Cancer 1 NSCLC 1 Melanoma 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Platinum Compounds 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03823625 2020-03-25

SQUINT

Fondazione Ricerca Traslazionale

Phase 2 Unknown

Squamous-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡